To view Article Recommendations, you must have an active subscription.
If your access has expired, you can subscribe at $9.95 per month, the first month of your subscription will be free of charge.
If you think you should be able to access this content, please contact us.
New to F1000? See this week’s top article below for a free preview of a Recommendation.
This randomized trial evaluated the efficacy of ketamine and bupivacaine in postoperative analgesia after surgical site infiltration in children undergoing cleft palate surgery. This trial is the first reporting ketamine site infiltration to be advantageous...
TOP RATED ARTICLE THIS WEEK [FREE TO VIEW]
7 Recommendations, most recent by
Past 7 Days
New Articles Recommended
Past 30 Days
358Articles Classified As Good for Teaching3,404 total
109Articles Classified As Review / Commentary5,611 total
167Articles Classified As Controversial8,003 total
107Articles Classified As Technical Advance7,021 total
355Articles Classified As Confirmation27,023 total
82Articles Classified As Novel Drug Target1,669 total
24Articles Classified As Refutation1,608 total
489Articles Classified As Clinical Trial27,430 total
9Articles Classified As Changes Clinical Practice3,958 total
209Articles Classified As Interesting Hypothesis14,417 total
746Articles Classified As New Finding50,326 total
Get instant access to Article Recommendations from more than 5,000 expert scientists and clinical researchers, assisted by 5,000 associates, by taking out a monthly subscription. The first month of your subscription will be free of charge.
Start your personal subscription today.Subscribe for $9.95/month
Send a recommendation to your institution's librarian or information manager to request an extended free trial for all users.Recommend to your Librarian
If you are a librarian or information manager, you may request an extended free trial for your academic or corporate institution.Request an Institutional Trial
your institution might be eligible for free access via our sponsorship scheme. Check our sponsorship page.